Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | DHFR | P00374 | 2/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.40 |
| ▸ | HTR1B | P28222 | 5/20 | 0.38 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | ADK | P55263 | 1/20 | 0.37 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.37 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29967345 | 1.00 | MAPT (0.50) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL29820187 | 0.89 | MAPT (0.63) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL1446528 | 0.89 | MAPT (0.63) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL29473526 | 0.84 | ALOX5 (0.57) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL12223406 | 0.84 | ALOX5 (0.57) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL7050380 | 0.82 | MAPT (0.39) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL30497792 | 0.82 | MAPT (0.39) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL30497791 | 0.82 | MAPT (0.39) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL12880138 | 0.82 | MAPT (0.75) | MAPTMEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL29512056 | 0.82 | MAPT (0.75) | MAPTMEN1KMT2AALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184503-A | Compound for identifying chiral amino alcohol, fluorescent probe, preparation method and application thereof | 海南大学 | 2024-06-14 | — | — | CN | claimed |
| CN-117567286-A | Fluorescent probe for specifically recognizing chiral threitol, preparation and application thereof | 海南大学 | 2024-02-20 | — | — | CN | claimed |
| CN-115340458-B | Compound for recognizing chiral arginine, fluorescent probe and preparation method thereof | 海南大学 | 2023-05-26 | — | — | CN | claimed |
| CN-114956975-A | Ammonia gas detection substance and device thereof | 海南大学 | 2022-08-30 | — | — | CN | claimed |
| CN-114591209-A | BINOL-based fluorescent probe, synthetic method thereof and application thereof in cadmium ion detection | 兰州大学 | 2022-06-07 | — | — | CN | claimed |
| CN-113233966-B | Chiral fluorescence sensor, preparation method thereof and application thereof in chiral amino acid recognition | 中国药科大学 | 2022-03-08 | — | — | CN | claimed |
| CN-113233966-A | Chiral fluorescence sensor, preparation method thereof and application thereof in chiral amino acid recognition | 中国药科大学 | 2021-08-10 | — | — | CN | claimed |
| CN-118184503-A | Compound for identifying chiral amino alcohol, fluorescent probe, preparation method and application thereof | 海南大学 | 2024-06-14 | — | — | CN | disclosed |
| CN-117567286-A | Fluorescent probe for specifically recognizing chiral threitol, preparation and application thereof | 海南大学 | 2024-02-20 | — | — | CN | disclosed |
| US-11685810-B2 | Process for polymerizing beta-butyrolactone | Technische Universität München (DE) | 2023-06-27 | — | — | US | disclosed |
| CN-114956975-B | Ammonia detection substance and device thereof | 海南大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-113979975-B | Chiral phosphoric acid catalyzed aryl allyl tertiary alcohol kinetic resolution method | 浙江工业大学 | 2023-02-28 | — | — | CN | disclosed |
| CN-113620901-B | Crown ether derived chiral 1,1 '-bi-2, 2' -naphthol, preparation method and application thereof | 杭州师范大学 | 2023-02-10 | — | — | CN | disclosed |
| US-7754899-B2 | Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-07-13 | — | — | US | disclosed |
| US-20100113835-A1 | Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100113815-A1 | Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-05-06 | — | — | US | disclosed |
| US-20100113835-A1 | Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-1452537-B1 | PROCESS FOR PREPARATION OF DIPHOSPHINE COMPOUNDS AND INTERMEDIATES FOR THE PROCESS | TAKEDA PHARMACEUTICAL (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20080081916-A1 | Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20080081916-A1 | Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081916-A1 | Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method | INTS9, RAD54L, CD99 | MAPT 3728/4885MEN1 983/4885KMT2A 2302/4885 |
| US-11685810-B2 | Process for polymerizing beta-butyrolactone | CYP17A1, COASY, BBOX1 | MAPT 1239/4885MEN1 1992/4885KMT2A 2970/4885 |
| US-20100113815-A1 | Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method | RAD54L, ATXN2L, CD99 | MAPT 3282/4885MEN1 1185/4885KMT2A 1663/4885 |
| US-20100113835-A1 | Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method | RAD54L, ATXN2L, CD99 | MAPT 3282/4885MEN1 1185/4885KMT2A 1663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.